Rana R. McKay

Dr. Rana McKay, a medical oncologist from UC San Diego specializing in prostate cancer, passionately discusses the role of androgen deprivation therapy (ADT) in treatment. She delves into the evolution of ADT options and emphasizes personalizing treatment to align with patient goals. The conversation also highlights the important role of PSA PET imaging in management and the shift between continuous and intermittent therapy. Plus, McKay advocates for better patient education to improve outcomes and minimize side effects in this crucial healthcare area.

Drs Sandhya Srinivas and Rana R. McKay discuss bone health, survivorship, and side effects of androgen deprivation therapy in patients with prostate cancer. They explore fracture risk assessment, use of bone protecting agents, and strategies for managing symptoms and promoting survivorship during hormonal therapy.

Dr. Rana McKay, an oncologist from UC San Diego Health with elite training from Harvard and Dana-Farber, unpacks the transformative triplet therapy for advanced prostate cancer. She explains how this innovative combo of ADT, ARPI, and chemotherapy outperforms traditional treatments. The discussion dives into timing for treatment escalation, personalizing care based on disease volume, and the use of genomic tools like the Decipher score in decision-making. Dr. McKay also touches on patient quality of life and the importance of integrating complementary strategies.